Table 1 |
||||
|
Clinical characteristics of the patients with rheumatoid arthritis |
||||
|
Patient |
Disease duration (months) |
Site of surgery |
Gender |
Medication |
|
|
||||
|
1 |
180 |
Knee |
Female |
Prednisolone, 5 mg/d; celecoxib, 200 mg/d; gasmotine, 2.5 mg/d |
|
2 |
36 |
Knee |
Female |
Cyclosporin A, 100 mg/d; triamcinolone, 2 mg/d |
|
3 |
240 |
Knee |
Male |
Prednisolone, 5 mg/d; hydroxychloroquine, 200 mg/d; sulfasalazine, 500 mg/d |
|
4 |
180 |
Hip |
Female |
Hydroxychloroquine, 200 mg/d |
|
5 |
187 |
Knee |
Female |
Deflazacort, 5 mg/d; methotrexate, 12.5 mg/wk; leflunomide, 10 mg/d; hydroxychloroquine, 200 mg/d |
|
|
||||
|
Kim et al. Arthritis Research & Therapy 2012 14:R187 doi:10.1186/ar4018 |
||||